Reshma Kewalramani, CEO & President at VERTEX PHARMACEUTICALS INC / MA (VRTX), sold 23,378 shares at $291.30 ($6.8M) on 2022-06-24, disclosed to the SEC on 2022-06-28.
Open-market sale of $6.8M VRTX by CEO & President. Not flagged as scheduled, tax-driven, or recurring — but no specific bearish signal from our filters. Reasons for insider sales vary widely.
Something here stands out, but not much.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $291.30 | 11,689 | $3.4M | 50.0% |
| 2 | $291.30 | 11,689 | $3.4M | 50.0% |
| Total | $291.30 avg | 23,378 | $6.8M | 100% |
| Filing → |
| VRTX | SELL | 2024-11-12 | $7.8M | — | Filing → |
| VRTX | SELL | 2024-08-01 | $7.7M | — | Filing → |
| VRTX | SELL | 2024-07-24 | $7.6M | — | Filing → |